Weihui Wu
Impact in
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Vibrio bacteria research studies
Papers in
-
- Antibiotic Resistance in Bacteria 66
-
- Vibrio bacteria research studies 31
Weihui Wu
112 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Molecular Medicine 765
- Endocrinology 445
- Microbiology 246
- Genetics 540
- Molecular Biology 1.3k
Countries citing papers authored by Weihui Wu
This map shows the geographic impact of Weihui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weihui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weihui Wu more than expected).
Fields of papers citing papers by Weihui Wu
This network shows the impact of papers produced by Weihui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weihui Wu. The network helps show where Weihui Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Weihui Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 3 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 23 | |
| 5 | Janus liposozyme for the modulation of redox and immune homeostasis in infected diabetic wounds Hit paper breakdown → | 2024 | 109 |
| 6 | 2024 | 2 | |
| 7 | 2023 | 3 | |
| 8 | 2022 | 4 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 4 | |
| 11 | 2019 | 28 | |
| 12 | 2019 | 17 | |
| 13 | 2018 | 20 | |
| 14 | 2017 | 30 | |
| 15 | 2016 | 53 | |
| 16 | 2016 | 39 | |
| 17 | 2016 | 14 | |
| 18 | 2015 | 7 | |
| 19 | 2012 | 108 | |
| 20 | 2006 | 27 |
About Weihui Wu
Weihui Wu is a scholar working on Molecular Medicine, Endocrinology, Genetics, Microbiology and Molecular Biology, having authored 120 papers that have together received 2.2k indexed citations. Recurring topics across this work include Bacterial biofilms and quorum sensing (67 papers), Antibiotic Resistance in Bacteria (66 papers), Bacterial Genetics and Biotechnology (47 papers), Vibrio bacteria research studies (31 papers), Bacteriophages and microbial interactions (10 papers), Antimicrobial Peptides and Activities (9 papers), Immune Response and Inflammation (7 papers) and RNA and protein synthesis mechanisms (6 papers). The work is most often cited by research in Molecular Medicine (765 citations), Endocrinology (445 citations), Microbiology (246 citations), Genetics (540 citations) and Molecular Biology (1.3k citations). Weihui Wu has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Shouguang Jin, Yongxin Jin, Zhihui Cheng, Fang Bai, Xiaolei Pan, Chang Liu, Ronghao Chen, Jing Shi, Yen-Michael S. Hsu and Xin Lin. Their work appears in journals such as Frontiers in Microbiology, Microbiology Spectrum, Antimicrobial Agents and Chemotherapy, Frontiers in Cellular and Infection Microbiology and Journal of Bacteriology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.